Pepric

Foundation date

14/04/2009

Sector

#Supplier & Engineering

Subsector

Therapeutic areas

Pepric provides pEPR (particle Electron Paramagnetic Resonance) instruments for in-vitro quantification of superparamagnetic nanoparticles in samples. Fast and accurate measurements by Pepric's robotized particle spectrometer are used for the preclinical tests of hyperthermia or (stem) cell therapies in oncology, cardiology, dermatology, and etc, and in vaccine developments by tracking the pharmacokinetics of therapeutic particles, (stem) cells, medicines or vaccine carriers that utilize super paramagnetic iron oxide nano particles (SPION) or magnetic nano particles (MNP).

Upcoming events

Latest news

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

  • Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023